Skip to Main Content

Print | Bookmark | Email | Font Size: + |

April 14, 2021

New and Revised Policies

CGS Administrators has two new policies and three revised policies that are currently in notice and will become active between April 25, 2021 to May 9, 2021.

  • L38773 Facet Joint Interventions for Pain Management effective May 2, 2021
  • L37836 MolDX: Androgen Receptor Variant (AR-V7) Protein Test effective May 9, 2021
  • L37832 MolDX: Breast Cancer Index┬« (BCI) Gene Expression Test effective May 2, 2021
  • L38771 Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease effective April 25, 2021
  • L38201 Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF) effective April 25, 2021

All comments received were reviewed before the finalization of the policies and if needed, updates were made accordingly. Please see the response to comments articles for the comments received by CGS during the open comment period for each policy which is attached to the policy in the related coverage documents section near the bottom of the policy. Policies can be accessed from the Part A Medical Policies web page, and the Part B Medical Policies web page.

spacer

26 Century Blvd Ste ST610, Nashville, TN 37214-3685 © CGS Administrators, LLC. All Rights Reserved